Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Recruiting 8Completed 5Active not recruiting 2Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

NIH 6OTHER 5INDUSTRY 3

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 4Sarcoma 1

Conditions

Neuroblastoma 4Neoplasm, Residual 1Leiomyosarcoma 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × OTHER × dinutuximab × Clear all
NCT02308527 2026-05-12

BEACON

University of Birmingham

Phase 2 Completed
225 enrolled
CNS

Neuroblastoma

NCT01857934 2026-04-16

Therapy for Children With Advanced Stage Neuroblastoma

St. Jude Children's Research Hospital

Phase 2 Completed
153 enrolled 12 charts
CNS

Neuroblastoma

NCT05080790 2025-08-17

DiTuSarc

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed
7 enrolled
Sarcoma

Leiomyosarcoma

NCT03332667 2025-04-16

MIBG With Dinutuximab +/- Vorinostat

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed
45 enrolled 16 charts
CNS

Neuroblastoma

NCT02169609 2024-04-22

Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma

Fundació Sant Joan de Déu

Phase 2 Completed
24 enrolled
CNS

Neuroblastoma, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡